The American Cancer Society estimates that 1,958,310 new cancer cases and 609,820 cancer deaths will occur in the United States in 2023. Cancer incidence trends show mixed results, with prostate cancer incidence increasing by 3% annually from 2014 to 2019, while other cancers like lung cancer in women decreased at a slower rate. Despite the pandemic, cancer death rates continued to decline, with a 1.5% decrease from 2019 to 2020, leading to a 33% overall reduction since 1991. This progress is largely due to advancements in treatment, particularly for leukemia, melanoma, and kidney cancer. However, rising incidence for breast, prostate, and uterine corpus cancers may hinder future progress, especially due to racial disparities in mortality. Cervical cancer incidence dropped by 65% among women in their early 20s from 2012 to 2019, reflecting the impact of the HPV vaccine. Cancer survival rates have improved, with the 5-year relative survival rate for all cancers increasing from 49% in the mid-1970s to 68% in 2012–2018. Survival improvements are particularly notable for cancers like melanoma and leukemia, which have seen significant declines in mortality rates. However, survival rates for uterine corpus cancer have not improved over the past 40 years, and Black women face higher mortality rates for all stages of this cancer. Cancer mortality rates have declined steadily since 1991, with a 33% reduction by 2020. The decline is driven by improvements in treatment, early detection, and screening. However, disparities persist, with Black individuals having significantly higher cancer mortality rates than White individuals. For example, Black women have the highest mortality rate for all histologic subtypes of uterine corpus cancer. Despite these disparities, the overall cancer death rate has decreased, with a 33% reduction from 215.1 per 100,000 persons in 1991 to 143.8 per 100,000 persons in 2020. Geographic variation in cancer occurrence is significant, with states like Kentucky having much higher cancer incidence and mortality rates than states like Utah and Puerto Rico. These differences are largely due to variations in risk factors, prevention practices, and access to care. The impact of the pandemic on cancer mortality has been significant, with a large increase in deaths from other causes, particularly heart disease, in 2020. The pandemic has also exacerbated existing racial and ethnic disparities in cancer outcomes. Overall, cancer remains a leading cause of death in the United States, with lung cancer being the leadingThe American Cancer Society estimates that 1,958,310 new cancer cases and 609,820 cancer deaths will occur in the United States in 2023. Cancer incidence trends show mixed results, with prostate cancer incidence increasing by 3% annually from 2014 to 2019, while other cancers like lung cancer in women decreased at a slower rate. Despite the pandemic, cancer death rates continued to decline, with a 1.5% decrease from 2019 to 2020, leading to a 33% overall reduction since 1991. This progress is largely due to advancements in treatment, particularly for leukemia, melanoma, and kidney cancer. However, rising incidence for breast, prostate, and uterine corpus cancers may hinder future progress, especially due to racial disparities in mortality. Cervical cancer incidence dropped by 65% among women in their early 20s from 2012 to 2019, reflecting the impact of the HPV vaccine. Cancer survival rates have improved, with the 5-year relative survival rate for all cancers increasing from 49% in the mid-1970s to 68% in 2012–2018. Survival improvements are particularly notable for cancers like melanoma and leukemia, which have seen significant declines in mortality rates. However, survival rates for uterine corpus cancer have not improved over the past 40 years, and Black women face higher mortality rates for all stages of this cancer. Cancer mortality rates have declined steadily since 1991, with a 33% reduction by 2020. The decline is driven by improvements in treatment, early detection, and screening. However, disparities persist, with Black individuals having significantly higher cancer mortality rates than White individuals. For example, Black women have the highest mortality rate for all histologic subtypes of uterine corpus cancer. Despite these disparities, the overall cancer death rate has decreased, with a 33% reduction from 215.1 per 100,000 persons in 1991 to 143.8 per 100,000 persons in 2020. Geographic variation in cancer occurrence is significant, with states like Kentucky having much higher cancer incidence and mortality rates than states like Utah and Puerto Rico. These differences are largely due to variations in risk factors, prevention practices, and access to care. The impact of the pandemic on cancer mortality has been significant, with a large increase in deaths from other causes, particularly heart disease, in 2020. The pandemic has also exacerbated existing racial and ethnic disparities in cancer outcomes. Overall, cancer remains a leading cause of death in the United States, with lung cancer being the leading